Otolaryngology · New Haven, CT
NPI
1548242977
Since 2005
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
46 Prince St
New Haven, CT, 06519
Phone (203) 752-1726
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
416 services
Medicare patients, 2024
279
Average age 73
Drug cost, 2024
$11K
747 prescriptions
Company payments, 2025
$149
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John F Kveton was code 99213 (office e&m - established), 259 times for 183 patients. In total John F Kveton billed 416 services in 24 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 259 | 183 | $62.83 | $16K |
| 99203 Office E&M - New | Office | 71 | 71 | $76.71 | $5,447 |
| 99214 Office E&M - Established | Office | 17 | 16 | $106.71 | $1,814 |
| 99204 Office E&M - New | Office | 16 | 16 | $122.60 | $1,962 |
By year: 2022 $53K for 432 services; 2023 $65K for 456 services; 2024 $51K for 416 services.
Medicare prescription drug claims, 2024
In 2024, the drug John F Kveton prescribed most often to Medicare patients was Triamterene-Hydrochlorothiazid (Triamterene/Hydrochlorothiazid), with 293 prescriptions and refills. In total John F Kveton wrote 747 Medicare prescriptions that cost $11K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 293 | 864 | 90 | $2,936 |
| Diazepam Generic | 165 | 168 | 48 | $888 |
| Ofloxacin Generic | 37 | 37 | 19 | $1,411 |
| Acetazolamide Generic | 34 | 102 | 14 | $1,275 |
| Hydrochlorothiazide Generic | 27 | 77 | Under 11 | $67.16 |
| Clonazepam Generic | 27 | 29 | Under 11 | $328 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 20 | 22 | Under 11 | $581 |
| Spironolactone Generic | 18 | 54 | Under 11 | $209 |
| Meclizine Hcl Generic | 16 | 16 | Under 11 | $112 |
| Lorazepam Generic | 14 | 14 | Under 11 | $223 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 | 12 | Under 11 | $47.98 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 12 | 13 | 12 | $659 |
| Methylprednisolone Generic | 11 | 11 | Under 11 | $63.35 |
Brand drugs: 20 claims; generic drugs: 727 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John F Kveton $149 ($149 in general payments such as food, travel and fees) from 1 company. The largest payer was Cochlear Americas with $149.
| Company | Payments | Amount |
|---|---|---|
| Cochlear Americas | 1 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.